Search
for
Sort by
Research 961–990 of 1000+
- The Molecular Basis of Blood Diseases
- A cross sectional study on geriatric dermatosis in patients attending a tertiary care hospital
- Safety and Efficacy of Mesotherapy with Placenta Polypeptide Injection for Moderate-to-Severe Sensitive Skin: A Multicenter, Randomized, Controlled Trial
- Efficacy of Cosmerna ARI in Improving Androgenetic Alopecia in Europeans: A Double-Blind, Randomized, Placebo-Controlled Clinical Trial over 6 months
- Steatocystomas: Update on Clinical Manifestations, Diagnosis, and Management
- Ethnomedicinal and Phytochemical Studies of Eclipta alba (A Review)
- LP-155 Psychosis as an early manifestation of neuropsychiatric systemic lupus erythematosus – a case report
- Diagnostic dilemma: Multiple Autoimmune Syndrome versus incomplete Graham-Little-Piccardi-Lassueur Syndrome overlap mixed connective tissue disease
- Folliculotropic mycosis fungoides
- Covid-19 in Lupus Nephritis
- Covid-19 in Lupus Nephritis
- 184 WITHDRAWN
- 185 Infrared and high frequency ultrasound imaging of skin lesions in atopic dermatitis and psoriasis vulgaris
- 182 Retinol remarkably effective in reducing neck wrinkles
- 176 The Prospective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) Study identifies clinical prognostic markers and establishes the foundation for large-scale translational research in cutaneous lymphoma
- 181 Association of demographic and hospital characteristics with emergency department visits due to sunburn
- Hair Loss and Hirsutism Management
- ANDROGEN-DEPENDENT DERMOPATHY IN WOMEN WITH KELOID SCARS
- British Hair and Nail Society
- CUTANEOUS MANIFESTATIONS OF LUPUS ERYTHEMATOSUS FROM A TERTIARY CARE CENTRE IN COASTAL KERALA
- 713 Fisetin promotes differentiation, inhibits proliferative and inflammatory responses in cultured human cells and alleviates psoriasiform dermatitis in mice
- 711 Small molecule wnt pathway inhibitor (SM04755) as a potential topical psoriasis treatment
- 708 SIG-1451: A topical anti-inflammatory new chemical entity for atopic dermatitis (AD)
- 709 Nitric oxide-releasing topical therapeutic agent for atopic dermatitis
- 710 Use of mass spectrometry imaging and a full thickness 3D skin equivalent for evaluation of percutaneous absorption
- 643 Male pattern baldness and risk of incident skin cancer in a cohort of men
- MECHANISM OF ACTION OF AVICENNIA MARINA HEARTWOOD EXTRACT AND AVICEQUINONE C ON HUMAN DERMAL PAPILLA CELLS ISOLATED FROM ANDROGENIC ALOPECIA PATIENTS
- Was the epidemic skin disease of 1891 due to acute arsenic poisoning?
- Cochlea hair cell rescue after a noise-induced hearing loss using a low level laser therapy (LLLT)
- Low-power laser use in the treatment of alopecia and crural ulcers